New antibodies in the area of peptide hormones and infectious diseases

Launch of new antibodies

December 2015

We are pleased to announce the launch of some more antibodies. We are doing our best to expand our portfolio in order to reach out to as many players as possible out there on the market.
One of our key competencies is metabolic markers, and therefore the antibody for Dipeptidyl peptidase-IV (DPP-IC/CD26) is an interesting target, which we are proud to add to our portfolio.

To read more about the new antibodies, click on the links:

 

Anti-MAP Kinase Substrate 1 (MKS1)
Anti-Dipeptidyl peptidase-IV (DPP-IV/CD26)
Anti-Filamentous Hemagglutinin (FHA)
Anti-Filamentous Hemagglutinin (FHA)